课题基金 / 基金详情

Bioimaging and theory for drug absorption in living cells

Bioimaging and theory for drug absorption in living cells
活细胞药物吸收的生物成像和理论
批准号:
06304044
负责人:
NAKANISHI Mamoru
金额:
$2.37万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Co-operative Research (A)
财政年份:
1994
资助国家:
日本
项目状态:
已结题
起止时间:
1994 至 1995

项目摘要

项目成果

NAKANISHI Mamoru的其他基金

相似基金

相关文献

中文摘要
翻译
一场光学显微镜的复兴和革命正在进行中。几项新技术与光学显微镜结合使用,已经产生了一种观察和测量活细胞中药物的新方法。新方法的一个主要贡献是使用计算机对图像进行数字处理和分析。新显微镜的第二个重要创新是多色荧光染料分子的发展,它代表了早期显微镜家所依赖的选择性染色的现代版本。在本项目中,我们尝试用新型光学显微镜研究活细胞中药物吸收的生物成像。我们对这一课题有了各种新的发现。分别是:转染IgE受体对P815肥大细胞瘤细胞表面CD63抗原表达的研究;电中性离子载体(莫能菌素)对磷脂双层膜电导变化的研究;药物生理药代动力学模型的应用与展望;肝脏根据半乳糖表面密度识别的半乳糖化蛋白;介导β -内酰胺类抗生素在肠道和肾脏吸收的大鼠H^+/肽解转运体的克隆和表征。因此,目前的合作研究补助金能够在活细胞药物吸收领域获得极高的收益。
英文摘要
A renaissance and a revolution in light microscopy are now under way. Several new technologies, used in conjunction with the light microscope, have yeilded a new way of seeing and measuring drugs in living cells. One major contribution to the new methodology is the use of computers for the digital processing and analysis of images. The second vital innovation in the new microscopy is the development of multicolor fluorescent dye molecules which represent a modern version ofselective stains relies on by earlier generations of microscopists. In this projects we have tried to study bioimaging for drug a bsorption in living cells by new light microscopes. We obtained various new findings for this subject. They were the studies of the surface expression of CD63 antigen in P815 mastocytoma cells by transfected IgE receptors, the conducance change in phospholipid bilayr membrace by an electroneutral ionophore (monensin), the application and prospects for physiologically based pharmacokinetic models involving pharmaceutical agents, the galactosylated proteins recognized by the liver according to the surface density of galactose, and cloning and characterization of rat H^+/peptidecotransporter mediating absorption of beta-lactam antibiotics in the intestine and kidney. Thus, the present Grant-in-Aid for Co-operative Research was able to obtain an extreemly high gool in the field of drug absorption in living cells.
期刊论文(30)
专著(0)
科研奖励(0)
会议论文
T.Furuno: "Surface expression of CD63 antigen(AD1 antigen)in P815 mastocytoma cells by transfected IgE receptors" Biochem.Biophys.Res.Commun.in press (1996)
T.Furuno:“通过转染的 IgE 受体在 P815 肥大细胞瘤细胞中表达 CD63 抗原(AD1 抗原)” Biochem.Biophys.Res.Commun.in press (1996)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
H Katayama: "Triggering of calcium signals in antigen-specific B cells on the supported lipid monolayers" Biochem.Biophys.Acta. 1266. 191-195 (1995)
H Katayama:“在支持的脂质单层上触发抗原特异性 B 细胞中的钙信号”Biochem.Biophys.Acta。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
中西守: "リンパ球のCa^<2+>動態" 細胞工学. 15. 240-246 (1996)
Mamoru Nakanishi:“淋巴细胞的Ca^2+动力学”《细胞工程》15. 240-246 (1996)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
M.Nakanishi: "Confocal fluorescence microscopy for studying signal transduction in mast cells and basophils." Zoological Studies. 34. 38-40 (1995)
M.Nakanishi:“用于研究肥大细胞和嗜碱性粒细胞信号转导的共聚焦荧光显微镜。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
29
    Neuro-immune cross talk with molecular imaging and medicine
    • 批准号:
      20390015
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.65万
    • 财政年份:
      2008
    • 负责人:
      NAKANISHI Mamoru
    • 依托单位:
    Immune-neuro Cross-talk with Confocal Laser Scanning Microscopy
    • 批准号:
      15390017
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.79万
    • 财政年份:
      2003
    • 负责人:
      NAKANISHI Mamoru
    • 依托单位:
    Gene transfection by cationic liposome with a cationic cholesterol derivative
    • 批准号:
      12557207
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $5.7万
    • 财政年份:
      2000
    • 负责人:
      NAKANISHI Mamoru
    • 依托单位:
    Dynamics of nuclear shuttling with MAP kinase
    • 批准号:
      12480202
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $4.42万
    • 财政年份:
      2000
    • 负责人:
      NAKANISHI Mamoru
    • 依托单位:
    海外基金